Turnstone Biologics (TSBX) Competitors $0.36 +0.00 (+0.61%) Closing price 04:00 PM EasternExtended Trading$0.36 +0.00 (+0.55%) As of 04:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TSBX vs. BDRX, SNYR, RNTX, SONN, CLNN, ESLA, SCYX, FGEN, DYAI, and ENLVShould you be buying Turnstone Biologics stock or one of its competitors? The main competitors of Turnstone Biologics include Biodexa Pharmaceuticals (BDRX), Synergy CHC (SNYR), Rein Therapeutics (RNTX), Sonnet BioTherapeutics (SONN), Clene (CLNN), Estrella Immunopharma (ESLA), SCYNEXIS (SCYX), FibroGen (FGEN), Dyadic International (DYAI), and Enlivex Therapeutics (ENLV). These companies are all part of the "pharmaceutical products" industry. Turnstone Biologics vs. Its Competitors Biodexa Pharmaceuticals Synergy CHC Rein Therapeutics Sonnet BioTherapeutics Clene Estrella Immunopharma SCYNEXIS FibroGen Dyadic International Enlivex Therapeutics Biodexa Pharmaceuticals (NASDAQ:BDRX) and Turnstone Biologics (NASDAQ:TSBX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership. Do analysts recommend BDRX or TSBX? Turnstone Biologics has a consensus price target of $0.45, indicating a potential upside of 24.31%. Given Turnstone Biologics' stronger consensus rating and higher possible upside, analysts clearly believe Turnstone Biologics is more favorable than Biodexa Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Biodexa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Turnstone Biologics 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Does the media refer more to BDRX or TSBX? In the previous week, Biodexa Pharmaceuticals had 2 more articles in the media than Turnstone Biologics. MarketBeat recorded 3 mentions for Biodexa Pharmaceuticals and 1 mentions for Turnstone Biologics. Turnstone Biologics' average media sentiment score of 1.89 beat Biodexa Pharmaceuticals' score of 0.62 indicating that Turnstone Biologics is being referred to more favorably in the news media. Company Overall Sentiment Biodexa Pharmaceuticals Positive Turnstone Biologics Very Positive Is BDRX or TSBX more profitable? Biodexa Pharmaceuticals' return on equity of 0.00% beat Turnstone Biologics' return on equity.Company Net Margins Return on Equity Return on Assets Biodexa PharmaceuticalsN/A N/A N/A Turnstone Biologics N/A -162.79%-124.10% Do institutionals and insiders believe in BDRX or TSBX? 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. Comparatively, 52.5% of Turnstone Biologics shares are held by institutional investors. 0.3% of Biodexa Pharmaceuticals shares are held by insiders. Comparatively, 32.1% of Turnstone Biologics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable earnings & valuation, BDRX or TSBX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiodexa PharmaceuticalsN/AN/A-$7.32MN/AN/ATurnstone BiologicsN/AN/A-$70.84M-$2.73-0.13 Which has more volatility & risk, BDRX or TSBX? Biodexa Pharmaceuticals has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500. Comparatively, Turnstone Biologics has a beta of 1.35, indicating that its stock price is 35% more volatile than the S&P 500. SummaryTurnstone Biologics beats Biodexa Pharmaceuticals on 6 of the 10 factors compared between the two stocks. Get Turnstone Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for TSBX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TSBX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TSBX vs. The Competition Export to ExcelMetricTurnstone BiologicsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.38M$2.93B$5.50B$9.39BDividend YieldN/A2.46%4.25%4.09%P/E Ratio-0.1320.3128.1019.86Price / SalesN/A261.57402.2879.25Price / CashN/A42.3835.5357.53Price / Book0.277.838.265.72Net Income-$70.84M-$55.11M$3.24B$257.80M7 Day Performance-1.76%2.18%0.50%1.06%1 Month Performance-3.39%12.98%7.99%11.30%1 Year Performance-85.58%1.98%28.68%17.00% Turnstone Biologics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TSBXTurnstone Biologics3.4156 of 5 stars$0.36+0.6%$0.45+24.3%-86.1%$8.38MN/A-0.1382Positive NewsBDRXBiodexa Pharmaceuticals0.2043 of 5 stars$0.88-10.2%N/AN/A$32.15M$470K0.0020SNYRSynergy CHC3.9353 of 5 stars$3.40+0.3%$10.00+194.1%N/A$31.25M$34.83M0.0040Positive NewsRNTXRein TherapeuticsN/A$1.40-6.7%N/AN/A$31.01MN/A-0.499Positive NewsGap DownSONNSonnet BioTherapeutics3.7771 of 5 stars$9.77+1.3%$20.00+104.7%+23.8%$30.97M$20K0.0010News CoverageGap DownHigh Trading VolumeCLNNClene3.4581 of 5 stars$3.70-0.8%$40.00+981.1%-23.1%$30.60M$340K-0.92100ESLAEstrella Immunopharma3.2935 of 5 stars$0.84-5.5%$16.00+1,813.9%-42.1%$30.24MN/A-3.22N/APositive NewsSCYXSCYNEXIS1.0737 of 5 stars$0.76-7.2%N/A-65.9%$29.66M$2.63M-1.3660Positive NewsFGENFibroGen4.7096 of 5 stars$7.32-4.8%$250.00+3,315.3%-73.6%$29.57M$29.62M-2.93570Positive NewsDYAIDyadic International3.1454 of 5 stars$0.98+1.1%$6.00+512.1%-35.9%$29.50M$3.34M-4.907Positive NewsGap UpENLVEnlivex Therapeutics2.8585 of 5 stars$1.23-3.9%$10.00+713.0%-12.8%$29.09MN/A-1.8670 Related Companies and Tools Related Companies Biodexa Pharmaceuticals Competitors Synergy CHC Competitors Rein Therapeutics Competitors Sonnet BioTherapeutics Competitors Clene Competitors Estrella Immunopharma Competitors SCYNEXIS Competitors FibroGen Competitors Dyadic International Competitors Enlivex Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TSBX) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Turnstone Biologics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Turnstone Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TSBX Stock Alerts